BridgeBio Pharma
Price & Volume
Stats
See moreOpen | $54.77 |
Previous Close | $54.79 |
Day Range | $54.72-$55.73 |
52W Range | $21.72-$55.33 |
Market Cap | $10.4B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $235.8M |
Revenue Growth (YoY) | 4,999.9% |
Gross Profit (12 Mos) | $226.8M |
Diluted EPS | -$4.13 |
News
See moreYahoo Finance • 7 days ago
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 8 days ago
BridgeBio Pharma, Inc. (BBIO) Retains $68 Target on Strong Launch Dynamics
Yahoo Finance • 12 days ago
Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM
Yahoo Finance • 15 days ago
Is Alnylam Pharmaceuticals (ALNY) an Undervalued Stock?
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Thomas Trimarchi Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 725 |
